Madrigal Pharmaceuticals Inc
(MDGL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,644 | -18,382 | -9,308 | 79,088 | 86,125 |
| Depreciation Amortization | 1,470 | 997 | 515 | 2,463 | 1,948 |
| Accounts receivable | -189 | -138 | -396 | 16,000 | 16,000 |
| Accounts payable and accrued liabilities | -1,564 | -2,677 | -2,495 | -5,668 | -5,089 |
| Other Working Capital | -5,998 | -6,399 | -4,883 | -112,940 | -111,082 |
| Other Operating Activity | 4,938 | 5,037 | 3,978 | -5,753 | -7,447 |
| Operating Cash Flow | $-29,987 | $-21,562 | $-12,589 | $-26,810 | $-19,545 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -19,213 | -6,047 | N/A | 21,503 | 4,563 |
| PPE Investments | -109 | -39 | N/A | -454 | -514 |
| Investing Cash Flow | $-19,322 | $-6,086 | $N/A | $21,049 | $4,049 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 15,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | -1,747 | -664 | -348 | -2,179 | -1,796 |
| Common Stock Issued | 26,807 | 26,768 | 26,699 | 50 | 50 |
| Financing Cash Flow | $40,060 | $26,104 | $26,351 | $-2,129 | $-1,746 |
| Beginning Cash Position | 44,155 | 44,155 | 44,155 | 52,045 | 52,045 |
| End Cash Position | 34,906 | 42,611 | 57,917 | 44,155 | 34,803 |
| Net Cash Flow | $-9,249 | $-1,544 | $13,762 | $-7,890 | $-17,242 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,987 | -21,562 | -12,589 | -26,810 | -19,545 |
| Capital Expenditure | -109 | -39 | N/A | -454 | -514 |
| Free Cash Flow | -30,096 | -21,601 | -12,589 | -27,264 | -20,059 |